<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635095">
  <TermName>HDAC inhibitor SNDX-275</TermName>
  <TermPronunciation>(... in-HIH-bih-ter ...)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor.  Also called entinostat and SNDX-275.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722599" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;HDAC inhibitor SNDX-275&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722600" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de HDAC SNDX-275&quot;" language="es" id="_4"/>
  <SpanishTermName>inhibidor de HDAC SNDX-275</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Bloquea enzimas necesarias para la división de las células y es posible que destruya células cancerosas. Es un tipo de inhibidor de la histona–desacetilasa (HDAC).  También se llama entinostat y SNDX-275.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-19</DateFirstPublished>
</GlossaryTerm>
